Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl


Preferences help
enabled [disable] Abstract
Number of results


2013 | 8 | 2 | 192-203

Article title

The efficacy of diode laser removal of leukoplakias on the tongue and in lower buccal cavity compared to other buccal cavity locations. A two-year study


Title variants

Languages of publication



Introduction. Leukoplakias of the buccal cavity are premalignant lesions with a significant 0–20% potential for malignant transformation. In addition to active follow-up screening procedures, a number of surgical interventions are recommended for their removal. One of the preferred procedures is laser ablation with consecutive histopathology using one of the many types of lasers. The efficacy of such procedure with respect to the lesion location is, however, unclear. Many studies are contradictory. Some shows laser ablations as prevention of malignisation other see it as increased risk. Aim of this is to test treatment in different locations for two years. Material and method. An outpatient ablation by a 980mm diode laser of lesions on the tongue and in the lower buccal cavity (Group A) and lesions in other parts of the buccal cavity (Group B) were performed under local anaesthesia. In total, 76 lesions were treated in 66 patients. Recurrence after 1, 3, 6, 9, 12, and 24 months were followed up. Initially, all lesions were histopathologically tested. Concurrently, the subjective tolerance of the procedure was monitored, using a 1 (ideal) to 5 (worst) scale. Results. Clearing rate of lesions was of 84.6% for Group A and of 94.7% for Group B. In two patients (3% of Group A) malignant transformation occurred which was not observed in Group B. Patient toleration in various time intervals was always higher in Group B, but generally was very high in both groups. Conclusion. Malignant transformation of leukoplakias does occur even after laser ablation, and for this reason it is necessary to subject the patients to systematic follow-ups. It is significantly higher risk of recurrences and malign transformation in tongue and oral base. Laser ablation is a simple and well-tolerated procedure with high clearing rate.










Physical description


1 - 4 - 2013
23 - 1 - 2013


  • Center of Photonic Medicine, Department of Oral and Maxillofacial Surgery, 1st Medical Faculty of Charles University, Prague and General Faculty Hospital, Praha 5, 155 21, Czech Republic
  • Department of Stomatology, 1st Medical Faculty, Charles University, Prague and General Faculty Hospital, 120 00, Prague, Czech Republic


  • [1] World Health Organization Collaborating Center for Precancerous Lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg 46:518–519, 1978 http://dx.doi.org/10.1016/0030-4220(78)90383-3[Crossref]
  • [2] Petti S: Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol 39:770–780, 2003 http://dx.doi.org/10.1016/S1368-8375(03)00102-7[Crossref]
  • [3] Axel T, Pindborg JJ, Smith CJ, van der Waal I: Oral white lesions with special reference to preprecancerous and tabacco-related lesions; conclusions of an international symposium held in Uppsala. Sweden, May 18–21 1994, International Collaborative group on Oral White Lesions. J Oral Pathol Med 25:49–54, 1994 http://dx.doi.org/10.1111/j.1600-0714.1996.tb00191.x[Crossref]
  • [4] Warnakulasutiya A: Lack of molecular markers to predict melignant potencial of oral precancer. J Pathol 190:407–409, 2000 http://dx.doi.org/10.1002/(SICI)1096-9896(200003)190:4<407::AID-PATH546>3.0.CO;2-D[Crossref]
  • [5] Van der Waal I, Schepman KP, van der Meij EH, Semele LE: Oral leukoplakia: a clinicopathological rewiew. Oral Oncol 33:291–301, 1997 http://dx.doi.org/10.1016/S1368-8375(97)00002-X[Crossref]
  • [6] Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, Benner SE, Xu XC, Lee JS, Papadimitrakopoulou VM, Geyer C, Perez C, Martin JW, El-Naggar AK, Lippman SM: Predicting cancer development in oral leukoplakia: Ten years of translational research. Clinical Cancer Research 6:1702–1710, 2000
  • [7] Vivek V, Jayasree RS, Balan A, Sreelatha KT, Gusta AK: Three-year follow-up of oral leukoplakia after neodymium: yttrium aluminium garnet (Nd:YAG) laser surgery. Lasers Med Sci 23:375–379, 2008 http://dx.doi.org/10.1007/s10103-007-0500-8[Crossref][WoS]
  • [8] Holmstrup P, Vedtofte P, Rebel J, Stolte K: Long-term treatment outcome of oral premalignant lesions. Oral Oncol 42:461–474, 2006 http://dx.doi.org/10.1016/j.oraloncology.2005.08.011[Crossref]
  • [9] Einhorn J, Wersall J: Incidence of oral carcinoma in patients with leukoplakia of oral mucosa. Cancer 20:2189–2193, 1967 http://dx.doi.org/10.1002/1097-0142(196712)20:12<2189::AID-CNCR2820201218>3.0.CO;2-M[Crossref]
  • [10] Yen AM, Chen SC, CHen TH: The effect of betel quid and cigarette on multistate progression of oral premalignancy. J Oral Pathol Med 37:417–422, 2008 http://dx.doi.org/10.1111/j.1600-0714.2008.00652.x[Crossref][WoS]
  • [11] Maserejian NN, Giovannucci E, Rosner B, Joshipur K: Prospective study of vitamins C, E, and A and carotenoids and risk of oral premalignant lesions in men. Int J Cancer 120:970–977, 2007 http://dx.doi.org/10.1002/ijc.22448[Crossref][WoS]
  • [12] Belevi B: Evidence-based decision-making: Should the general dentist adopt the use of the VELscope fot routine screening for oral cancer? J Can Dent Assoc 73:603–606, 2007
  • [13] Pindborg JJ, Barmes D, Oedpete B (1968) Epidemiology and histology of oral leukoplakia and leukoedema among Papuans and New Guineans. Cancer 22:379–384 http://dx.doi.org/10.1002/1097-0142(196808)22:2<379::AID-CNCR2820220215>3.0.CO;2-A[Crossref]
  • [14] Sahiar BE, Daftary DK, Mehta FS: Cytological and histological keratinization studies in leukoplakias of the mouth. J Oral Pathol Med 4:19–26, 1975 http://dx.doi.org/10.1111/j.1600-0714.1975.tb01736.x[Crossref]
  • [15] Pandey M, Thomas G, Somanathan T, Sankaranarayanan R, Abraham EK, Jacob BJ, Mathew B: Evaluation of surgical excision of nonhomogeneous oral leukoplakia in a screening intervention trial, Kerala, India. Oral Oncol 37:102–109, 2001 http://dx.doi.org/10.1016/S1368-8375(00)00070-1[Crossref]
  • [16] Saito T, Sugiura C, Hirai A, Notani K, Totsuka Y, Shindoh M, Fukuda H: Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respekt to treatment modality. Int J Oral Maxillofac Surg 30:49–53, 2001 http://dx.doi.org/10.1054/ijom.2000.0012[Crossref]
  • [17] Ishii J, Fujita K, Munemoto S, Komori T: Management of oral leukoplakia by laser surgery: relation between recurrence and malignant transformation and clinicopathological features. J Clin Laser Med Surg 22:27–33, 2004 http://dx.doi.org/10.1089/104454704773660949[Crossref]
  • [18] Ishii J, Fujita K, Komori T: Laser surgery as a treatment for oral leukoplakia. Oral Oncol 39:759–769, 2003 http://dx.doi.org/10.1016/S1368-8375(03)00043-5[Crossref]
  • [19] Hamadah O, Thomson PJ: Factors affecting carbon dioxide laser treatment for oral precancer: A patient cohort study. Lasers Surg Med 41:17–25, 2009 http://dx.doi.org/10.1002/lsm.20733[Crossref][WoS]
  • [20] Gooris PJJ, Roodenburg JLN, Fermež A, Nauta JM: Carbon dioxide laser evaporation of leukoplakia of the lower lip: a retrospective evaluation. Oral Oncol 35:490–497, 1999 http://dx.doi.org/10.1016/S1368-8375(99)00022-6[Crossref]
  • [21] Martorell-Calatayud, A., R. Botella-Estrada, et al.: Oral leukoplakia: clinical, histopathologic, and molecular features and therapeutic approach. Actas Dermosifiliogr 100(8): 669–684, 2009 http://dx.doi.org/10.1016/S0001-7310(09)72280-X[Crossref]

Document Type

Publication order reference


YADDA identifier

JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.